Research Points to Translational Path Toward Precision Immunotherapies for EGFR-Mutant NSCLC

… Research presented at the 2026 American Association for Cancer Research (AACR) Immuno-Oncology Conference (AACR IO) … Yongfeng He, PhD, Assistant Professor of Cancer Biology Research within the Department of Cardiothoracic Surgery at …

Wu-Kong28 Data Support Sunvozertinib as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

From Sequencing to Treatment: The Role of Comprehensive Genome Profiling, Molecular Tumor Boards in Advanced-Stage NSCLC

… Gap Precision oncology in NSCLC has moved decisively from research to clinical practice. The FPG500 program demonstrated … A. Gemelli IRCCS in Rome, Italy. His main clinical and research interests are centered on precision oncology and … information to support translational and clinical research projects. Emilio Bria Dr. Bria is a Medical …

Keynote Address Explores the Future of Biomarkers in the ADC Era

… R. Hirsch outlined the current state of knowledge in ADC research, as well as what still needs to be learned. … Keynote …

Arrhythmias after Radiotherapy—What Do (and Don’t) We Know?

… Researchers examine emerging data demonstrating that …

Artificial Intelligence in Thoracic Radiation Oncology: Treatment, Challenges, and Future Directions